Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 11 de 11
Revista Panamericana de Salud Pblica/Pan American Journal of Public Health ; 46(Special Issue Emergency), 2022.
Article in Spanish | CAB Abstracts | ID: covidwho-2247159
Agronoma Mesoamericana ; 34(1), 2022.
Article in Spanish | CAB Abstracts | ID: covidwho-2272691
Cancer Epidemiology, Biomarkers & Prevention ; 30(7 Suppl):4-114, 2021.
Article in English | CAB Abstracts | ID: covidwho-2044470
CGIAR Research Program on Policies, Institutions, and Markets ; 2022.
Article in English | CAB Abstracts | ID: covidwho-2033653
Weekly Epidemiological Record ; 96(46):557-567, 2021.
Article in English, French | CAB Abstracts | ID: covidwho-2010646
IJID Reg ; 5: 21-29, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-1996275


Introduction: Coronavirus disease 2019 (COVID-19)-associated mucormycosis (CAM) became a public health problem in India in 2021. However, information about the incidence, presentation and prognosis of CAM remains sparse. Methods: This study describes 100 cases from the Surgically treated Post COVID Acute invasive fungal Rhino-Orbital Sinusitis in Chandrapur (SPAROS) study, a prospective observational follow-up study of patients with CAM diagnosed in Chandrapur district, India. Two-step cluster analysis using four input variables - blood glucose on admission, diabetes status, glucocorticoid exposure and severity of COVID-19 - was used to define three distinct CAM clusters. Results: The incidence of CAM in the general population was 7.1 cases/1000 patients hospitalized with COVID-19. Steroid exposure and pre-existing diabetes were present in 76% and 55% of cases, respectively. At median follow-up of 18 days, only two deaths had been recorded, while 93 cases were stable. Glucocorticoids, particularly methylprednisolone, seemed to precipitate CAM. Admission to the intensive care unit appeared to be predictive of less extensive surgery. Discussion: Three subtypes of CAM were identified: COVID-19-associated diabetes and mucormycosis, COVID-19-associated classical mucormycosis, and COVID-19-induced mucormycosis. A CAM hypothesis was proposed based on the dynamics of severe acute respiratory syndrome coronavirus-2 and glucose regulated protein. Conclusion: The clinical characteristics, natural course and pathogenesis of CAM differ from mucormycosis in the pre-COVID era. It is hoped that this classification will be useful in CAM management.

WIDER Working Papers ; 41(19), 2022.
Article in English | GIM | ID: covidwho-1965137
Human Organization ; 80(4):322-331, 2021.
Article in English | CAB Abstracts | ID: covidwho-1755573
Revista de Patologia Tropical ; 50(1):73-75, 2021.
Article in English | CAB Abstracts | ID: covidwho-1726548
International Journal of Travel Medicine and Global Health ; 9(3):119-123, 2021.
Article in English | CAB Abstracts | ID: covidwho-1559754